As of 2025-02-19, the Intrinsic Value of Dynavax Technologies Corp (DVAX) is
3.89 USD. This DVAX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 12.82 USD, the upside of Dynavax Technologies Corp is
-69.62%.
DVAX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(58.10) - (19.76) |
(28.90) |
-325.4% |
| DCF (Growth 10y) |
(27.07) - (76.74) |
(38.98) |
-404.0% |
| DCF (EBITDA 5y) |
(2.39) - (2.21) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(1.85) - (0.60) |
(1,234.50) |
-123450.0% |
| Fair Value |
3.89 - 3.89 |
3.89 |
-69.62% |
| P/E |
5.62 - 9.48 |
7.36 |
-42.6% |
| EV/EBITDA |
(0.61) - (0.49) |
(0.56) |
-104.3% |
| EPV |
10.91 - 14.26 |
12.59 |
-1.8% |
| DDM - Stable |
1.83 - 6.87 |
4.35 |
-66.1% |
| DDM - Multi |
1.30 - 3.78 |
1.93 |
-84.9% |
DVAX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,685.19 |
| Beta |
0.50 |
| Outstanding shares (mil) |
131.45 |
| Enterprise Value (mil) |
1,789.42 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.01% |
| Cost of Debt |
5.97% |
| WACC |
7.77% |